Overgaard J, Dahl O, Arcangeli G
Acta Oncol. 2024; 63:943-949.
PMID: 39665330
PMC: 11656068.
DOI: 10.2340/1651-226X.2024.41035.
Van Dieren L, Quisenaerts T, Licata M, Beddok A, Lellouch A, Ysebaert D
Cancers (Basel). 2024; 16(21).
PMID: 39518094
PMC: 11545184.
DOI: 10.3390/cancers16213656.
Prokhorova A, Helbig M
Sensors (Basel). 2024; 24(18).
PMID: 39338647
PMC: 11435978.
DOI: 10.3390/s24185902.
Szasz A
Bioengineering (Basel). 2024; 11(7).
PMID: 39061807
PMC: 11273694.
DOI: 10.3390/bioengineering11070725.
Lin T, Jia J, Luo W, Lin X, Xiao S, Yang J
J Exp Clin Cancer Res. 2024; 43(1):62.
PMID: 38419081
PMC: 10903011.
DOI: 10.1186/s13046-024-02983-3.
A Review of the Current Clinical Evidence for Loco-Regional Moderate Hyperthermia in the Adjunct Management of Cancers.
Chia B, Ho S, Tan H, Chua M, Tuan J
Cancers (Basel). 2023; 15(2).
PMID: 36672300
PMC: 9856725.
DOI: 10.3390/cancers15020346.
Answer to Commentary on "Systematic review about complementary medical hyperthermia in oncology" by Liebl et al.
Hubner J, Dorfler J, Liebl C, Kasmann L
Clin Exp Med. 2022; 22(4):673-678.
PMID: 36239870
PMC: 9588464.
DOI: 10.1007/s10238-022-00901-5.
Commentary on "Systematic review about complementary medical hyperthermia in oncology" by Liebl et al.
Arrojo E, Fiorentini G, Ghadjar P, Minnaar C, Szasz A, Szasz A
Clin Exp Med. 2022; 22(4):667-672.
PMID: 36239869
PMC: 9588469.
DOI: 10.1007/s10238-022-00902-4.
Clinical magnetic hyperthermia requires integrated magnetic particle imaging.
Healy S, Bakuzis A, Goodwill P, Attaluri A, Bulte J, Ivkov R
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022; 14(3):e1779.
PMID: 35238181
PMC: 9107505.
DOI: 10.1002/wnan.1779.
Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment.
Ademaj A, Veltsista D, Ghadjar P, Marder D, Oberacker E, Ott O
Cancers (Basel). 2022; 14(3).
PMID: 35158893
PMC: 8833668.
DOI: 10.3390/cancers14030625.
Feasibility, SAR Distribution, and Clinical Outcome upon Reirradiation and Deep Hyperthermia Using the Hypercollar3D in Head and Neck Cancer Patients.
Kroesen M, van Holthe N, Sumser K, Chitu D, Vernhout R, Verduijn G
Cancers (Basel). 2021; 13(23).
PMID: 34885258
PMC: 8656471.
DOI: 10.3390/cancers13236149.
Patient-Specific Planning for Thermal Magnetic Resonance of Glioblastoma Multiforme.
Oberacker E, Diesch C, Nadobny J, Kuehne A, Wust P, Ghadjar P
Cancers (Basel). 2021; 13(8).
PMID: 33919701
PMC: 8070230.
DOI: 10.3390/cancers13081867.
Quo Vadis Oncological Hyperthermia (2020)?.
Lee S, Fiorentini G, Szasz A, Szigeti G, Szasz A, Minnaar C
Front Oncol. 2020; 10:1690.
PMID: 33014841
PMC: 7499808.
DOI: 10.3389/fonc.2020.01690.
Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses.
Datta N, Kok H, Crezee H, Gaipl U, Bodis S
Front Oncol. 2020; 10:819.
PMID: 32596144
PMC: 7303270.
DOI: 10.3389/fonc.2020.00819.
The Survival Benefit of Combination Therapy With Mild Temperature Hyperthermia and an Herbal Prescription of Gun-Chil-Jung in 54 Cancer Patients Treated With Chemotherapy or Radiation Therapy: A Retrospective Study.
Jun H, Park S, Kang H, Lee G, Lee N, Park J
Integr Cancer Ther. 2020; 19:1534735420926583.
PMID: 32449629
PMC: 7249570.
DOI: 10.1177/1534735420926583.
The Effect of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in 400 Locally Advanced Cervical Carcinoma Patients.
Kroesen M, Mulder H, van Holthe J, Aangeenbrug A, Mens J, van Doorn H
Front Oncol. 2019; 9:134.
PMID: 30906734
PMC: 6418024.
DOI: 10.3389/fonc.2019.00134.
Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia.
Elming P, Sorensen B, Oei A, Franken N, Crezee J, Overgaard J
Cancers (Basel). 2019; 11(1).
PMID: 30634444
PMC: 6356970.
DOI: 10.3390/cancers11010060.
First in vitro evidence of modulated electro-hyperthermia treatment performance in combination with megavoltage radiation by clonogenic assay.
McDonald M, Corde S, Lerch M, Rosenfeld A, Jackson M, Tehei M
Sci Rep. 2018; 8(1):16608.
PMID: 30413777
PMC: 6226525.
DOI: 10.1038/s41598-018-34712-0.
Biologically Targeted Magnetic Hyperthermia: Potential and Limitations.
Chang D, Lim M, Goos J, Qiao R, Ng Y, Mansfeld F
Front Pharmacol. 2018; 9:831.
PMID: 30116191
PMC: 6083434.
DOI: 10.3389/fphar.2018.00831.
Magnetic resonance-guided high-intensity focused ultrasound combined with radiotherapy for palliation of head and neck cancer-a pilot study.
Lee J, Farha G, Poon I, Karam I, Higgins K, Pichardo S
J Ther Ultrasound. 2016; 4:12.
PMID: 27042308
PMC: 4818916.
DOI: 10.1186/s40349-016-0055-x.